Avanos Medical (AVNS) Interest Expenses (2013 - 2026)

Avanos Medical has disclosed Interest Expenses across 14 years of filings, most recently posting $1.5 million for Q1 2026.

• Interest Expenses for Q1 2026 came in at $1.5 million, down 28.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.2 million (down 35.71% YoY), and the FY2025 annual result was $7.8 million, down 36.07% from the prior year.
• Interest Expenses came in at $1.5 million for Q1 2026 at Avanos Medical, down from $1.9 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $4.7 million in Q3 2023 to a low of $1.3 million in Q1 2022.
• The 5-year median for Interest Expenses is $3.0 million (2022), against an average of $2.7 million.
• Across the five-year window, Interest Expenses soared 328.57% in 2022 and tumbled 43.75% in 2025, its largest moves.
• Avanos Medical's Interest Expenses stood at $3.0 million in 2022, then gained by 10.0% to $3.3 million in 2023, then slipped by 15.15% to $2.8 million in 2024, then plunged by 32.14% to $1.9 million in 2025, then declined by 21.05% to $1.5 million in 2026.
• The last three Interest Expenses figures came in at $1.5 million (Q1 2026), $1.9 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.